Assessing the quality of antenatal corticosteroids in low- and middle-income countries: A systematic review.
Euodia MosoroAlyce N WilsonCaroline S E HomerJoshua Peter VogelPublished in: PloS one (2020)
Poor quality maternal and newborn health medicines can endanger women and newborns. Though available evidence on antenatal corticosteroids quality in LMICs is limited, results suggested poor quality dexamethasone may be prevalent in some countries. More primary studies are required to confirm these findings and guide policymakers on procurement of good-quality maternal and newborn health medicines.